Tuberculosis, a re-emergent disease.

[1]  F. Antunes,et al.  [Multi-drug-resistant tuberculosis in a Department of Infectious Diseases]. , 2004, Acta medica portuguesa.

[2]  F. Antunes,et al.  Smear microscopy to diagnose tuberculosis early and prevent further transmission in a population with a high prevalence of HIV infection. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  T. Ottenhoff,et al.  Tuberculin Skin Testing Compared with T-Cell Responses to Mycobacterium tuberculosis-Specific and Nonspecific Antigens for Detection of Latent Infection in Persons with Recent Tuberculosis Contact , 2001, Clinical Diagnostic Laboratory Immunology.

[4]  A. Bhargava.  WHO report 2000 , 2001, The Lancet.

[5]  C. Dye,et al.  The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. , 2001, The Journal of infectious diseases.

[6]  Christopher Dye,et al.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 2001, The New England journal of medicine.

[7]  M. Hannan,et al.  Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. , 2001, The Journal of hospital infection.

[8]  C. Henschke,et al.  Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. , 2000, Archives of internal medicine.

[9]  C. Dye,et al.  Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China. , 2000, International journal of epidemiology.

[10]  P. Brown.  Drug resistant tuberculosis can be controlled, says WHO , 2000, BMJ : British Medical Journal.

[11]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[12]  J. Moniz-Pereira,et al.  Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  J. Porter,et al.  Twice weekly tuberculosis preventive therapy in HIV infection in Zambia , 1998, AIDS.

[14]  Christopher Dye,et al.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy , 1998, The Lancet.

[15]  P. Prandoni,et al.  Ultrasonography of contralateral veins in patients with unilateral deep-vein thrombosis , 1998, The Lancet.

[16]  A. Infuso,et al.  An outbreak of multidrug‐resistant tuberculosis involving HIV‐infected patients of two hospitals in Milan, Italy , 1998, AIDS.

[17]  G L French,et al.  An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. , 1998, The Journal of hospital infection.

[18]  R. Chaisson,et al.  Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection , 1998, The Lancet.

[19]  M. Vjecha,et al.  A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. , 1997, The New England journal of medicine.

[20]  A. Gonzaga,et al.  Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  M. Vjecha,et al.  Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration. , 1996, American journal of respiratory and critical care medicine.

[22]  T. Frieden,et al.  Tuberculosis in New York City--turning the tide. , 1995, The New England journal of medicine.

[23]  D E Snider,et al.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. , 1995, JAMA.

[24]  F. Mosteller,et al.  Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature , 1994 .

[25]  S. Levin.  EFFECT OF ISONIAZID PROPHYLAXIS ON INCIDENCE OF ACTIVE TUBERCULOSIS AND PROGRESSION OF HIV INFECTION Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr. Lancet. 1993;342: 268–72 , 1993 .

[26]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[27]  J. T. Crawford,et al.  Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. , 1993, The Journal of infectious diseases.

[28]  J. Pape,et al.  Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection , 1993, The Lancet.

[29]  K. D. de Cock,et al.  Tuberculosis and HIV infection in sub-Saharan Africa. , 1992, JAMA.

[30]  Christopher J. L. Murray,et al.  Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.

[31]  M. Fischl,et al.  An Outbreak of Tuberculosis Caused by Multiple-Drug-resistant Tubercle Bacilli among Patients with HIV Infection , 1992, Annals of Internal Medicine.

[32]  G. Schoolnik,et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.

[33]  K. Brudney,et al.  Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control Programs , 1991, The American review of respiratory disease.

[34]  R. Hayes,et al.  Impact of HIV on tuberculosis in Zambia: a cross sectional study. , 1990, BMJ.

[35]  A. Pitchenik,et al.  Outbreaks of drug-resistant tuberculosis at AIDS centre , 1990, The Lancet.

[36]  R. Luzzati,et al.  NOSOCOMIAL EPIDEMIC OF ACTIVE TUBERCULOSIS AMONG HIV-INFECTED PATIENTS , 1989, The Lancet.

[37]  S. Vermund,et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[38]  I. Onorato,et al.  Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[39]  C. Nacy,et al.  Detection of active tuberculosis by an MPB-64 transdermal patch: a field study. , 2001, Scandinavian journal of infectious diseases.

[40]  A. Infuso,et al.  Effectiveness of infection control measures in controlling a nosocomial outbreak of multidrug-resistant tuberculosis among HIV patients in Italy. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[41]  A. Harries,et al.  Tuberculosis and HIV: current status in Africa. , 1997, AIDS.

[42]  R. Shafer,et al.  Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessment. , 1995, The Journal of infectious diseases.

[43]  M. Raviglione,et al.  Secular trends of tuberculosis in western Europe. , 1993, Bulletin of the World Health Organization.